據國際文傳電訊社：俄羅斯稱其部隊已佔領烏克蘭頓涅茨克地區的阿爾捷馬（Artema）。

歡迎進入鏈接網頁右側下載本週財經數據與事件精美周曆壁紙：今日有6000億元六個月期買斷式逆回購到期，七國集團（G7）峯會開幕

Baili Tianheng (02615.HK) said its in-house bispecific ADC iza-bren (BL-B01D1) has had a marketing application for triple-negative breast cancer accepted by the National Medical Products Administration’s Center for Drug Evaluation. The filing covers treatment of unresectable locally advanced or metastatic TNBC in patients who progressed on prior taxane therapy. This is the drug’s third MAA acceptance by the CDE, after submissions for nasopharyngeal carcinoma and esophageal squamous cell carcinoma.